HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Guggulsterones induce apoptosis and differentiation in acute myeloid leukemia: identification of isomer-specific antileukemic activities of the pregnadienedione structure.

Abstract
In this study, the antileukemic effects of three isomeric pregnadienedione steroids [i.e., cis-guggulsterone, trans-guggulsterone, and 16-dehydroprogesterone] were investigated in HL60 and U937 cells as well as in primary leukemic blasts in culture. Our results show that all three compounds inhibited the proliferation of HL60 and U937 cells, with IC50s ranging from 3.6 to 10.9 micromol/L after treatment for 6 days. These growth inhibitory effects correlated with externalization of phosphatidylserine and loss of mitochondrial membrane potential, suggesting that these isomeric steroids induce apoptosis in leukemia cells. z-VAD-fmk prevented phosphatidylserine externalization but not mitochondrial membrane potential loss, indicating that mitochondrial dysfunction occurred in the absence of caspase activation. Interestingly, although all three compounds increased the generation of reactive oxygen species and decreased phosphorylation of extracellular signal-regulated kinase, only cis-guggulsterone induced a rapid depletion of reduced glutathione levels and oxidation of the mitochondrial phospholipid cardiolipin. 16-Dehydroprogesterone and trans-guggulsterone induced differentiation of HL60 and NB4 cells as evidenced by increased surface expression of CD11b and/or CD14, and all three steroids rapidly induced mitochondrial dysfunction and phosphatidylserine externalization of CD34-positive blasts from primary leukemic samples. This study is the first to show that guggulsterones and 16-dehydroprogesterone exert antileukemic effects via the induction of apoptosis and differentiation and, more importantly, identifies the pregnadienedione structure as a potential chemotherapeutic scaffold.
AuthorsIsmael Samudio, Marina Konopleva, Stephen Safe, Teresa McQueen, Michael Andreeff
JournalMolecular cancer therapeutics (Mol Cancer Ther) Vol. 4 Issue 12 Pg. 1982-92 (Dec 2005) ISSN: 1535-7163 [Print] United States
PMID16373713 (Publication Type: Journal Article)
Chemical References
  • Antineoplastic Agents
  • Cardiolipins
  • Pregnadienes
  • Pregnenediones
  • Reactive Oxygen Species
  • Progesterone
  • pregna-4,17-diene-3,16-dione
  • Heme Oxygenase (Decyclizing)
  • Extracellular Signal-Regulated MAP Kinases
  • Glutathione
  • 16-dehydroprogesterone
Topics
  • Acute Disease
  • Antineoplastic Agents (pharmacology)
  • Apoptosis (drug effects)
  • Blotting, Western
  • Cardiolipins (metabolism)
  • Cell Differentiation (drug effects)
  • Extracellular Signal-Regulated MAP Kinases (metabolism)
  • Flow Cytometry
  • Glutathione (metabolism)
  • HL-60 Cells
  • Heme Oxygenase (Decyclizing) (metabolism)
  • Humans
  • Isomerism
  • Leukemia, Myeloid (metabolism, pathology)
  • Phosphorylation
  • Pregnadienes (chemistry, pharmacology)
  • Pregnenediones (chemistry, pharmacology)
  • Progesterone (analogs & derivatives, pharmacology)
  • Reactive Oxygen Species
  • U937 Cells

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: